Literature DB >> 8528702

Early, but not late, antiepileptic treatment reduces relapse of sound-induced seizures in the post-ischemic rat.

V G Iyer1, K H Reid, C Young, J Miller, A Schurr.   

Abstract

Global ischemia was used to induce a sensitivity to sound-triggered generalized seizures in 24 male Long-Evans rats. All showed a generalized seizure when exposed to a 108 dB bell for 1 min. They were assigned randomly to 3 groups of 8, and received 30 additional sound exposures. The early treatment group was injected with valproate (200 mg/kg i.p) 1 h prior to each of the first 10 sound exposures. The late treatment group received the same treatment during the second set of 10 sound exposures after 10 sound exposures without treatment. The third group was untreated. Both early and late treated groups had a significant reduction in seizure incidence during the treatment period, i.e. both groups showed seizure control. However, in the late group seizures returned promptly when valproate treatment was discontinued, while the early group showed a sustained reduction in seizure susceptibility. Since this outcome corresponds to seizure remission, the findings of this study favor early treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8528702     DOI: 10.1016/0006-8993(95)00608-s

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered.

Authors:  Joseph Deutsch; Stanley I Rapoport; Thad A Rosenberger
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

2.  Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice.

Authors:  Shanu George; Shilpa D Kadam; Natasha D Irving; Geoffrey J Markowitz; Saba Raja; Anthony Kwan; Yushan Tu; Huigen Chen; Charles Rohde; Dani R Smith; Anne M Comi
Journal:  Front Cell Neurosci       Date:  2013-08-19       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.